Show items per page
Elements: 8
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F 2011
add to browser selection
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... Gabay, Cem 2012
add to browser selection
The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers Kearsley-Fleet, Lianne; Závada, Jakub; Hetland, Merete Lund; Nordström, Dan C; ... Hyrich, Kimme L 2015
add to browser selection
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study Gabay, Cem; Riek, Myriam; Hetland, Merete Lund; Hauge, Ellen-Margrethe; ... Kvien, Tore K 2016
add to browser selection
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... van Vollenhoven, Ronald F 2016
add to browser selection
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis Walker, Ulrich A; Jaeger, Veronika K; Chatzidionysiou, Katerina; Hetland, Merete L; ... Gabay, Cem 2016
add to browser selection
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration Lauper, Kim; Nordström, Dan C; Pavelka, Karel; Hernández, Maria Victoria; ... Gabay, Cem 2018
add to browser selection
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Kristianslund, Eirik K; ... Gabay, Cem 2019